These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 377589)

  • 1. Development of donor-specific B lymphocyte antibodies after renal transplantation. No correlation with graft outcome.
    Ting A; Morris PJ
    Transplantation; 1979 Jul; 28(1):13-7. PubMed ID: 377589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of B cell alloantibodies to renal allograft survival.
    Mohanakumar T; Giedlin MA; Rhodes CL; DuVall CH; Mendez-Picon G; Kaplan AM; Lee HM
    Transplantation; 1979 Apr; 27(4):273-8. PubMed ID: 375503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and specificity of anti-B lymphocyte antibodies in renal allograft recipients.
    Fauchet R; Genetet B; Campion JP; Watelet J; Minet J; Cartier F; Launois B
    Transplantation; 1980 Aug; 30(2):114-7. PubMed ID: 7010705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-specific B and T lymphocyte antibodies and kidney graft survival.
    Jeannet M; Benzonana G; Arni I
    Transplantation; 1981 Mar; 31(3):160-3. PubMed ID: 7015609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful renal transplantation in patients with T-cell reactivity to donor.
    Cardella CJ; Falk JA; Nicholson MJ; Harding M; Cook GT
    Lancet; 1982 Dec; 2(8310):1240-3. PubMed ID: 6128547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
    Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
    Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between treatment-resistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens.
    Soulillou JP; Peyrat MA; Guenel J
    Lancet; 1978 Feb; 1(8060):354-6. PubMed ID: 75395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal transplantation and a positive serological cross-match.
    Morris PJ; Oliver DO; Williams K; Ting A; Bishop M; Dunnill MS
    Lancet; 1977 Jun; 1(8025):1288-91. PubMed ID: 68386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood B cells producing donor-specific HLA antibodies in vitro.
    Han M; Rogers JA; Lavingia B; Stastny P
    Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion.
    Cheigh JS; Suthanthiran M; Kaplan M; Evelyn M; Riggio RR; Fotino M; Schechter N; Wolf CF; Stubenbord WT; Stenzel KH
    Transplantation; 1984 Nov; 38(5):501-6. PubMed ID: 6238460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-B cell lymphocytotoxic antibodies in kidney transplant recipients.
    Lepage V; Gluckman JC; Bedrossian J; Duboust A; Nebout T; Bracq C; Rudloff MC; Dausset J
    Transplantation; 1978 May; 25(5):255-8. PubMed ID: 349801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection.
    Cai J; Terasaki PI; Zhu D; Lachmann N; Schönemann C; Everly MJ; Qing X
    Exp Mol Pathol; 2016 Feb; 100(1):45-50. PubMed ID: 26615783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.